Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2007
12/12/2007CN101086012A Method for quick cloning and identifying bacteria beta-galactosidase gene
12/12/2007CN101086011A Edible mushroom and plant double-strand RNA virus detection kit and its uses
12/12/2007CN101086010A Dedicated primer for trichogram matids molecular identification and method for identifying trichogram matids
12/12/2007CN101086009A Temperature-control matrix biochip and its processing method
12/12/2007CN101086008A Quality control standard substance for microbe detection and its preparation method
12/12/2007CN101085986A SARS coronavirus disturbance RNA and its uses
12/12/2007CN101085982A Preparation method for producing microbe polysaccharides formulation using lactobacillus and microzyme
12/12/2007CN101085974A Biochip hybridization procedure optimization control method and apparatus employing the method
12/12/2007CN101085346A Attenuated pestiviruses
12/12/2007CN101084914A Application of ophiopognin saponin D in preparing vascular endothelial cells apoptosis regulating gene medicine
12/12/2007CN101084913A Application of ophiopognin saponin D in preparing vascular endothelial cells regulating signal transduction gene medicine
12/12/2007CN100354630C Reagent for testing calcium in sample and test method thereof
12/12/2007CN100354431C Method of PCR testing of pooled blood samples
12/12/2007CN100354430C Rapid and sensitive detection of cells and viruses
12/12/2007CN100354429C Rapid and sensitive detection of molecules
12/12/2007CN100354428C Method for preparing endotoxin indicator in use testing dry heat sterilization devices in tunnel type
12/12/2007CN100354418C Polyfunctional support material for complex nucleic acid analysis
12/12/2007CN100354307C NOGO receptor-mediated blockade of axonal growth
12/12/2007CN100354305C Mage-A1 peptides presented by HLA class II molecules
12/12/2007CN100354012C Testing body, particularly for verifying the penetration properties of a sterilizing agent in sterilization processes
12/12/2007CN100354009C Method for producing sterilized and calibrated medical device based on biological sensor
12/11/2007US7308364 Diagnosis of multiple myeloma on gene expression profiling
12/11/2007US7307158 Selection marker gene
12/11/2007US7307154 DNA encoding a novel RG1 polypeptide
12/11/2007US7307144 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
12/11/2007US7307143 Conductin protein and a related agent for diagnosing and treating tumor illnesses
12/11/2007US7307069 Inflammatory diseases and cancers; promotion of apoptosis; may have phosphorothioate, 2'-O-(2-methoxyethyl) sugar, and/or 5-methyl cytosine modifications; useful prophylactically, and as clinical research and diagnostic tools.
12/11/2007US7306950 Composition and use of substances for stabilising amino acids containing sulphur
12/11/2007US7306945 Fragment of alpha-synuclein is contacted with a drug; reduction in the rate or extent of aggregation fragment of alpha-synuclein relative to a control lacking the agent indicates the agent has the pharmacological activity
12/11/2007US7306942 Bcillus anthracis by chelating calcium of endospores; reacting with aequorin to generate a light pulse which can then be detected by a standard liquid scintillation spectrometer
12/11/2007US7306939 Genetic engineering
12/11/2007US7306938 High throughput screen for inhibitors of fatty acid biosynthesis in bacteria
12/11/2007US7306933 Method for producing L-lysine or L-threonine
12/11/2007US7306930 Method bacterial endospore quantification using lanthanide dipicolinate luminescence
12/11/2007US7306929 Method for controlled release of enzymatic reaction components
12/11/2007US7306928 Homogenous assay for enzymatic activity
12/11/2007US7306927 Diagnosing cancer in humans; obtain sample, detect expression of chymotrypsin, presence of chymotrypsin enzyme indicates cancer
12/11/2007US7306925 Phage antibodies to radiation-inducible neoantigens
12/11/2007US7306924 Biosensor and related method
12/11/2007US7306923 Methods for identification, and compounds useful for the treatment of degenerative & inflammatory diseases
12/11/2007US7306920 Gene associated with regulation of energy balance, obesity and diabetes and uses therefor
12/11/2007US7306918 Testing of an organism and correlating the results with a unique marker (single nucleotide polymorphism or short tandem repeats) that identifies the sample; contacting a target sequence with oligonucleotide probes, interrogating the hybridization complexes, decoding
12/11/2007US7306917 Structure-specific nuclease activity of a variety of enzymes is used to cleave the target-dependent cleavage structure, thereby indicating the presence of specific nucleic acid sequences or specific variations
12/11/2007US7306916 Methods for detecting chromosome aberrations
12/11/2007US7306915 Nucleic acid contained even in a very small amount in a sample can be detected with a strong signal; nucleic acids, proteins, hormones, neurotransmitters, autacoids, haptens, viruses or cells of microorganisms, pollens, does not require thermal denaturation
12/11/2007US7306914 Protein fragment complementation assays in whole animals applications to drug efficacy, ADME, cancer biology, immunology, infectious disease and gene therapy
12/11/2007US7306913 Using single nucleotide polymorphisms to diagnose cardiovascular and vascular disorders
12/11/2007US7306912 Method for two-dimensional conformation-dependent separation of non-circular nucleic acids
12/11/2007US7306911 KCNJ2 gene or the Kir2.1 is screened for alteration as compared to the wild-type sequence; alteration in a copy of the KCNJ2 gene or a Kir2.1 polypeptide indicates high risk for developing a cardiac dysrhythmia and can be diagnosed with Andersen's Syndrome
12/11/2007US7306910 Using gene expression profile of tumor cells to diagnose and prognose mammary gland cell proliferative disorders
12/11/2007US7306909 Canola event pv-bngt04(rt73) and compositions and methods for detection thereof
12/11/2007US7306908 Mutant Dna; transcription of genomes
12/11/2007US7306907 Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors
12/11/2007US7306906 Engineered templates and their use in single primer amplification
12/11/2007US7306905 Detecting therapeutic agents in sample; obtain cell, expose to oxidatve stress, incubate with therapeutic agent, monitor response, reduced damage due to oxidative stress indicates preventive or therapeutic agent
12/11/2007US7306904 Detecting and counting preferential particles in sample; obtain probes, allow to bind to target particles, monitor associations between probe and targegt perticles
12/11/2007US7306903 Use of test cells comprising DNA defining a morphogen-responsive transcription activating element operatively associated with reporter gene, increase in expression of detectable gene product after exposing test cell to candidate compound indicates ability of compound to induce morphogen-mediated effect
12/11/2007US7306902 Detecting ras-activated neoplastic cells by contacting sample with a reovirus and determining its ability to replicate; use in diagnosis and treatment of interferon-sensitive, p53/Rb deficient tumors
12/11/2007US7306901 Methods and means for assessing HIV envelope inhibitor therapy
12/11/2007US7306807 Immunize cats, veterinary medicine
12/11/2007US7306804 HIV-specific T-cell induction
12/11/2007US7306795 PRO5774 antibodies
12/11/2007US7306783 Complexing; drug delivery; in situ imaging; detection apoptosis
12/11/2007CA2348245C Treatment of rumen acidosis with .alpha.-amylase inhibitors
12/11/2007CA2338673C Method and apparatus for detecting viruses using primary and secondary biomarkers
12/11/2007CA2224426C Cis-9,10-octadecenoamidase
12/11/2007CA2188463C Pharmaceutical compositions containing activated protein c-resistant factor v for the treatment of bleeding disorders
12/11/2007CA2171618C Purine nucleoside phosphorylase gene therapy for human malignancy
12/11/2007CA2120002C Cytodiagnostic method using alstonine as a selective marker, and diagnostic kit containing said marker
12/11/2007CA2073630C Method for synthesizing single-stranded stem-loop dnas, the products and uses therefor
12/06/2007WO2007140474A2 Compositions and methods for detection and modulation of t cell mediated immune responses against viral vectors utilized for gene therapy
12/06/2007WO2007140417A2 Methods and compositions for the extraction and amplification of nucleic acid from a sample
12/06/2007WO2007140388A2 Ablation based laser machining of biomolecule patterns on substrates
12/06/2007WO2007140335A2 Screening methods and transgenic animals for treatment of beta-globin related diseases and conditions
12/06/2007WO2007140319A1 Methylated promoters as biomarkers of colon cancer
12/06/2007WO2007140308A2 Methods of screening for trpm4 modulators of insulin secretion
12/06/2007WO2007140287A2 Use of biomarkers of inflammation as indicators of drug efficacy
12/06/2007WO2007140279A2 Probes and kits for determining the presence of mycobacterium tuberculosis complex organisms in a test sample and method of amplifying gram-positive bacteria and fungi employing capture probe
12/06/2007WO2007140253A2 Treatment of hiv-1 by modulation of vpr activation of the m-csf promoter
12/06/2007WO2007140015A2 Biochemical analysis of partitioned cells
12/06/2007WO2007139989A2 Tissue sample preparation, and maldi ms imaging thereof
12/06/2007WO2007139985A2 Cooperating oncogenes in cancer
12/06/2007WO2007139935A1 Innate immune response inducer
12/06/2007WO2007139811A1 Methods and kits for linking polymorphic sequences to expanded repeat mutations
12/06/2007WO2007139779A2 Identification of genes or polypeptides the expression of which correlates to fertility, ovarian function and/or fetal/newborn viability
12/06/2007WO2007139769A1 Composition and method for treating esophageal dysplasia
12/06/2007WO2007139601A2 Phenotypic engineering of spore
12/06/2007WO2007139598A2 Metastasis-associated gene profiling for identification of tumor tissue, subtyping, and prediction of prognosis of patients
12/06/2007WO2007139547A1 Polymorphisms in mitochondrial transcription factor a (tfam) gene and their associations with carcass traits
12/06/2007WO2007139546A2 Polymorphisms in fatty acid binding protein 4(“fabp4”) gene and their associations with carcass traits
12/06/2007WO2007139411A2 Fast assignment of adequate neoadjuvant chemotherapy for breast cancer patients based on the identification of constitutional brca1 mutations
12/06/2007WO2007139386A1 Totv-resistant plants
12/06/2007WO2007139373A1 Identification of tumor suppressor genes in an acute myeloid leukaemia model
12/06/2007WO2007139229A1 Light-inducible and rhythmically expressed genes and method for screening substances that affect an internal clock system
12/06/2007WO2007139201A1 Organism specimen imaging method and organism specimen imaging device
12/06/2007WO2007139144A1 Cell chip
12/06/2007WO2007139100A1 Method of examining soil pollution and/or water pollution
12/06/2007WO2007139089A1 Improved method of determining chemical
12/06/2007WO2007139080A1 Continuous assay method for measuring receptor- and ion channel-mediated calcium response and subsequent gene expression
12/06/2007WO2007139013A1 Flavin adenine dinucleotide-binding glucose dehydrogenase